Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism

Human mesenchymal stem cells (hMSCs) are being increasingly pursued as potential therapies for immune-mediated conditions, including multiple sclerosis. Although they can suppress human Th1 responses, they reportedly can reciprocally enhance human Th17 responses. Here, we investigated the mechanisms...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Transl Med
Main Authors: Rozenberg, Ayal, Rezk, Ayman, Boivin, Marie-Noëlle, Darlington, Peter J., Nyirenda, Mukanthu, Li, Rui, Jalili, Farzaneh, Winer, Raz, Artsy, Elinor A., Uccelli, Antonio, Reese, Jane S., Planchon, Sarah M., Cohen, Jeffrey A., Bar-Or, Amit
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2016
Assuntos:
Cell-Based Drug Development, Screening, and Toxicology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070498/
https://ncbi.nlm.nih.gov/pubmed/27400792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados